

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cerebellar Purkinje cell differentiation (GO:0021702) | 8.93906417 |
| 2 | thalamus development (GO:0021794) | 8.84351359 |
| 3 | peptidyl-arginine omega-N-methylation (GO:0035247) | 8.74238472 |
| 4 | bone trabecula formation (GO:0060346) | 8.52918063 |
| 5 | positive regulation of gastrulation (GO:2000543) | 8.46494868 |
| 6 | forebrain neuron development (GO:0021884) | 8.27447345 |
| 7 | neurotransmitter catabolic process (GO:0042135) | 8.24746192 |
| 8 | urogenital system development (GO:0001655) | 8.22439974 |
| 9 | peptidyl-arginine methylation (GO:0018216) | 8.07397139 |
| 10 | peptidyl-arginine N-methylation (GO:0035246) | 8.07397139 |
| 11 | cerebellum development (GO:0021549) | 7.39328346 |
| 12 | spinal cord association neuron differentiation (GO:0021527) | 7.12499861 |
| 13 | histone arginine methylation (GO:0034969) | 7.10581133 |
| 14 | somite rostral/caudal axis specification (GO:0032525) | 6.34305516 |
| 15 | head development (GO:0060322) | 6.21657296 |
| 16 | primitive streak formation (GO:0090009) | 6.13271688 |
| 17 | uterus development (GO:0060065) | 5.96857165 |
| 18 | retina layer formation (GO:0010842) | 5.83875881 |
| 19 | hematopoietic stem cell proliferation (GO:0071425) | 5.78534918 |
| 20 | endoderm formation (GO:0001706) | 5.66695525 |
| 21 | vagina development (GO:0060068) | 5.52283270 |
| 22 | glomerulus development (GO:0032835) | 5.41120495 |
| 23 | embryonic viscerocranium morphogenesis (GO:0048703) | 5.21464105 |
| 24 | cell differentiation in hindbrain (GO:0021533) | 5.14206613 |
| 25 | peptidyl-arginine modification (GO:0018195) | 5.13380023 |
| 26 | behavioral response to nicotine (GO:0035095) | 5.09917671 |
| 27 | granulocyte differentiation (GO:0030851) | 5.07096618 |
| 28 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 4.95662703 |
| 29 | viral protein processing (GO:0019082) | 4.76908294 |
| 30 | central nervous system neuron development (GO:0021954) | 4.70265319 |
| 31 | positive regulation of protein homooligomerization (GO:0032464) | 4.58667902 |
| 32 | female genitalia development (GO:0030540) | 4.54585320 |
| 33 | cranial nerve structural organization (GO:0021604) | 4.51622568 |
| 34 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 4.49404260 |
| 35 | long term synaptic depression (GO:0060292) | 4.37200510 |
| 36 | pattern specification involved in kidney development (GO:0061004) | 4.23205946 |
| 37 | telencephalon development (GO:0021537) | 4.15702795 |
| 38 | S-adenosylmethionine metabolic process (GO:0046500) | 4.15085889 |
| 39 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.11212140 |
| 40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.06796605 |
| 41 | positive regulation of T cell apoptotic process (GO:0070234) | 4.05319964 |
| 42 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 3.88825642 |
| 43 | motor neuron axon guidance (GO:0008045) | 3.84596023 |
| 44 | neurotransmitter metabolic process (GO:0042133) | 3.84278129 |
| 45 | cellular biogenic amine catabolic process (GO:0042402) | 3.84129704 |
| 46 | amine catabolic process (GO:0009310) | 3.84129704 |
| 47 | regulation of neuron migration (GO:2001222) | 3.83876800 |
| 48 | adult feeding behavior (GO:0008343) | 3.81332543 |
| 49 | positive regulation of protein kinase C signaling (GO:0090037) | 3.63908769 |
| 50 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.52752387 |
| 51 | catechol-containing compound biosynthetic process (GO:0009713) | 3.41143901 |
| 52 | catecholamine biosynthetic process (GO:0042423) | 3.41143901 |
| 53 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.40881850 |
| 54 | regulation of thymocyte apoptotic process (GO:0070243) | 3.38406338 |
| 55 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 3.34119447 |
| 56 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.33729409 |
| 57 | cornea development in camera-type eye (GO:0061303) | 3.28579606 |
| 58 | facial nerve structural organization (GO:0021612) | 3.26384418 |
| 59 | membrane repolarization during action potential (GO:0086011) | 3.25183532 |
| 60 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.23240271 |
| 61 | exocrine pancreas development (GO:0031017) | 3.21719586 |
| 62 | regulation of sarcomere organization (GO:0060297) | 3.21565244 |
| 63 | negative regulation of multicellular organism growth (GO:0040015) | 3.18264084 |
| 64 | imidazole-containing compound metabolic process (GO:0052803) | 3.15465235 |
| 65 | resolution of meiotic recombination intermediates (GO:0000712) | 3.10038832 |
| 66 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 3.09261787 |
| 67 | cell differentiation in spinal cord (GO:0021515) | 3.08936272 |
| 68 | organic cation transport (GO:0015695) | 3.07308685 |
| 69 | neuron fate specification (GO:0048665) | 3.03857069 |
| 70 | regulation of triglyceride catabolic process (GO:0010896) | 3.01916219 |
| 71 | positive regulation of mesonephros development (GO:0061213) | 2.91314010 |
| 72 | virion assembly (GO:0019068) | 2.89227414 |
| 73 | DNA double-strand break processing (GO:0000729) | 2.88351479 |
| 74 | anatomical structure arrangement (GO:0048532) | 2.86477029 |
| 75 | dendritic spine morphogenesis (GO:0060997) | 2.86134339 |
| 76 | positive regulation of embryonic development (GO:0040019) | 2.83838753 |
| 77 | determination of adult lifespan (GO:0008340) | 2.81470100 |
| 78 | trabecula formation (GO:0060343) | 2.80206926 |
| 79 | connective tissue development (GO:0061448) | 2.74746461 |
| 80 | forebrain neuron differentiation (GO:0021879) | 2.73866007 |
| 81 | synaptic transmission, cholinergic (GO:0007271) | 2.70194497 |
| 82 | nucleobase catabolic process (GO:0046113) | 2.69454676 |
| 83 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.64101802 |
| 84 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 2.63587442 |
| 85 | regulation of hippo signaling (GO:0035330) | 2.63234681 |
| 86 | retinal ganglion cell axon guidance (GO:0031290) | 2.61200194 |
| 87 | negative regulation of axon guidance (GO:1902668) | 2.55338894 |
| 88 | negative regulation of interleukin-1 production (GO:0032692) | 2.53267649 |
| 89 | phenol-containing compound biosynthetic process (GO:0046189) | 2.51684528 |
| 90 | autophagic vacuole fusion (GO:0000046) | 2.51443614 |
| 91 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.47750153 |
| 92 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.46803314 |
| 93 | lymphangiogenesis (GO:0001946) | 2.46465766 |
| 94 | organelle membrane fusion (GO:0090174) | 2.45948500 |
| 95 | polyamine metabolic process (GO:0006595) | 2.45151266 |
| 96 | centriole replication (GO:0007099) | 2.44219495 |
| 97 | DNA demethylation (GO:0080111) | 2.42851604 |
| 98 | ubiquinone biosynthetic process (GO:0006744) | 2.41999606 |
| 99 | regulation of T cell tolerance induction (GO:0002664) | 2.41758881 |
| 100 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 11.3921857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.61939515 |
| 2 | IGF1R_20145208_ChIP-Seq_DFB_Human | 4.39527479 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.70219136 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.93237205 |
| 5 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.72861336 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.41294542 |
| 7 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.37126441 |
| 8 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 2.36015102 |
| 9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.22833769 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.22505266 |
| 11 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.17872151 |
| 12 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.11275705 |
| 13 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.01558008 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.98661211 |
| 15 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.97179953 |
| 16 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.93429522 |
| 17 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.89734074 |
| 18 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.89508931 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.83521844 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.83267442 |
| 21 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.79885691 |
| 22 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.79772758 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.69631115 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.69343837 |
| 25 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.64506800 |
| 26 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.62128311 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.58742896 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.55814001 |
| 29 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.45312101 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44902478 |
| 31 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.38276964 |
| 32 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.38233368 |
| 33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.37913852 |
| 34 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.35812491 |
| 35 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.35416651 |
| 36 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35089968 |
| 37 | EWS_26573619_Chip-Seq_HEK293_Human | 1.34583950 |
| 38 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.33413313 |
| 39 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.33413313 |
| 40 | NCOR_22424771_ChIP-Seq_293T_Human | 1.32058927 |
| 41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.31118009 |
| 42 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.28424605 |
| 43 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.27967332 |
| 44 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27162232 |
| 45 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.25021499 |
| 46 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.24165720 |
| 47 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.23308856 |
| 48 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23308856 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22413202 |
| 50 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21664166 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21577868 |
| 52 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.21446441 |
| 53 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.21277294 |
| 54 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.19319508 |
| 55 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.18870464 |
| 56 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.17622630 |
| 57 | P300_19829295_ChIP-Seq_ESCs_Human | 1.17014895 |
| 58 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16475950 |
| 59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15416628 |
| 60 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.15376646 |
| 61 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.15376646 |
| 62 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.13446409 |
| 63 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12511162 |
| 64 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11462857 |
| 65 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.10811107 |
| 66 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10695149 |
| 67 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.10341876 |
| 68 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.09808918 |
| 69 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.08255537 |
| 70 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07767284 |
| 71 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.06872445 |
| 72 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.06287285 |
| 73 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.05512296 |
| 74 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.05233081 |
| 75 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.04643025 |
| 76 | CBP_21632823_ChIP-Seq_H3396_Human | 1.04210209 |
| 77 | AR_20517297_ChIP-Seq_VCAP_Human | 1.04062044 |
| 78 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.03989917 |
| 79 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03836266 |
| 80 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.03230397 |
| 81 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.03041559 |
| 82 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.02993622 |
| 83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02514112 |
| 84 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01713430 |
| 85 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99443230 |
| 86 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99104035 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98963910 |
| 88 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.97216735 |
| 89 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96924637 |
| 90 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.96762762 |
| 91 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.95160216 |
| 92 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94948294 |
| 93 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.94502235 |
| 94 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.94502235 |
| 95 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.93553089 |
| 96 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.92829924 |
| 97 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.92495911 |
| 98 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.92340318 |
| 99 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91210856 |
| 100 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.90087160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 4.23843825 |
| 2 | MP0002138_abnormal_hepatobiliary_system | 4.03533867 |
| 3 | MP0003880_abnormal_central_pattern | 4.02749794 |
| 4 | MP0003890_abnormal_embryonic-extraembry | 3.85960172 |
| 5 | MP0001188_hyperpigmentation | 3.47003433 |
| 6 | MP0005257_abnormal_intraocular_pressure | 3.13120303 |
| 7 | MP0002653_abnormal_ependyma_morphology | 2.84640923 |
| 8 | MP0005171_absent_coat_pigmentation | 2.48703605 |
| 9 | MP0006276_abnormal_autonomic_nervous | 2.45837758 |
| 10 | MP0003938_abnormal_ear_development | 2.34711741 |
| 11 | MP0000049_abnormal_middle_ear | 2.14341788 |
| 12 | MP0002127_abnormal_cardiovascular_syste | 2.04806510 |
| 13 | MP0006292_abnormal_olfactory_placode | 10.4718987 |
| 14 | MP0000538_abnormal_urinary_bladder | 1.99593216 |
| 15 | MP0008995_early_reproductive_senescence | 1.94014015 |
| 16 | MP0010368_abnormal_lymphatic_system | 1.84424348 |
| 17 | MP0002184_abnormal_innervation | 1.79423886 |
| 18 | MP0008775_abnormal_heart_ventricle | 1.78063970 |
| 19 | MP0003195_calcinosis | 1.76578473 |
| 20 | MP0005083_abnormal_biliary_tract | 1.76414213 |
| 21 | MP0001501_abnormal_sleep_pattern | 1.67820168 |
| 22 | MP0001879_abnormal_lymphatic_vessel | 1.65299930 |
| 23 | MP0005248_abnormal_Harderian_gland | 1.63997402 |
| 24 | MP0001849_ear_inflammation | 1.53257918 |
| 25 | MP0008789_abnormal_olfactory_epithelium | 1.40664993 |
| 26 | MP0001502_abnormal_circadian_rhythm | 1.37245189 |
| 27 | MP0005174_abnormal_tail_pigmentation | 1.36788717 |
| 28 | MP0000955_abnormal_spinal_cord | 1.36124165 |
| 29 | MP0001286_abnormal_eye_development | 1.27219155 |
| 30 | MP0004381_abnormal_hair_follicle | 1.26389321 |
| 31 | MP0005670_abnormal_white_adipose | 1.23365813 |
| 32 | MP0003879_abnormal_hair_cell | 1.17488764 |
| 33 | MP0001485_abnormal_pinna_reflex | 1.16545274 |
| 34 | MP0002102_abnormal_ear_morphology | 1.11197113 |
| 35 | MP0006072_abnormal_retinal_apoptosis | 1.10718804 |
| 36 | MP0004742_abnormal_vestibular_system | 1.09265978 |
| 37 | MP0005220_abnormal_exocrine_pancreas | 1.08428096 |
| 38 | MP0009115_abnormal_fat_cell | 1.08276038 |
| 39 | MP0008932_abnormal_embryonic_tissue | 1.07632168 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.06789194 |
| 41 | MP0002837_dystrophic_cardiac_calcinosis | 1.05389715 |
| 42 | MP0000778_abnormal_nervous_system | 1.02070922 |
| 43 | MP0002272_abnormal_nervous_system | 0.98844747 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 0.98793694 |
| 45 | MP0003646_muscle_fatigue | 0.96844686 |
| 46 | MP0000026_abnormal_inner_ear | 0.96645681 |
| 47 | MP0003385_abnormal_body_wall | 0.96603439 |
| 48 | MP0005394_taste/olfaction_phenotype | 0.91859559 |
| 49 | MP0005499_abnormal_olfactory_system | 0.91859559 |
| 50 | MP0003948_abnormal_gas_homeostasis | 0.91455819 |
| 51 | MP0004085_abnormal_heartbeat | 0.91265266 |
| 52 | MP0002210_abnormal_sex_determination | 0.90539016 |
| 53 | MP0002876_abnormal_thyroid_physiology | 0.90312706 |
| 54 | MP0001873_stomach_inflammation | 0.87868955 |
| 55 | MP0001984_abnormal_olfaction | 0.87700872 |
| 56 | MP0000534_abnormal_ureter_morphology | 0.86479806 |
| 57 | MP0002557_abnormal_social/conspecific_i | 0.85092831 |
| 58 | MP0003638_abnormal_response/metabolism_ | 0.84832998 |
| 59 | MP0002882_abnormal_neuron_morphology | 0.84322642 |
| 60 | MP0001968_abnormal_touch/_nociception | 0.83683634 |
| 61 | MP0009745_abnormal_behavioral_response | 0.83509943 |
| 62 | MP0003315_abnormal_perineum_morphology | 0.83474956 |
| 63 | MP0008872_abnormal_physiological_respon | 0.81402423 |
| 64 | MP0002095_abnormal_skin_pigmentation | 0.80523719 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 0.79857067 |
| 66 | MP0002735_abnormal_chemical_nociception | 0.75271569 |
| 67 | MP0003698_abnormal_male_reproductive | 0.73347344 |
| 68 | MP0000015_abnormal_ear_pigmentation | 0.72846464 |
| 69 | MP0002877_abnormal_melanocyte_morpholog | 0.70787852 |
| 70 | MP0002752_abnormal_somatic_nervous | 0.69634405 |
| 71 | MP0005075_abnormal_melanosome_morpholog | 0.67931799 |
| 72 | MP0001145_abnormal_male_reproductive | 0.67680592 |
| 73 | MP0004885_abnormal_endolymph | 0.67280637 |
| 74 | MP0001963_abnormal_hearing_physiology | 0.66978585 |
| 75 | MP0003567_abnormal_fetal_cardiomyocyte | 0.64165666 |
| 76 | MP0001970_abnormal_pain_threshold | 0.62779886 |
| 77 | MP0004147_increased_porphyrin_level | 0.62514500 |
| 78 | MP0005423_abnormal_somatic_nervous | 0.60327130 |
| 79 | MP0003959_abnormal_lean_body | 0.59719670 |
| 80 | MP0005448_abnormal_energy_balance | 0.59544672 |
| 81 | MP0003936_abnormal_reproductive_system | 0.58622338 |
| 82 | MP0002152_abnormal_brain_morphology | 0.58278181 |
| 83 | MP0002971_abnormal_brown_adipose | 0.58043255 |
| 84 | MP0003724_increased_susceptibility_to | 0.57143414 |
| 85 | MP0000653_abnormal_sex_gland | 0.56358739 |
| 86 | MP0001929_abnormal_gametogenesis | 0.54925257 |
| 87 | MP0003045_fibrosis | 0.54779028 |
| 88 | MP0003635_abnormal_synaptic_transmissio | 0.53350186 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.53242055 |
| 90 | MP0001324_abnormal_eye_pigmentation | 0.53050741 |
| 91 | MP0000613_abnormal_salivary_gland | 0.51276305 |
| 92 | MP0002163_abnormal_gland_morphology | 0.51148043 |
| 93 | MP0002572_abnormal_emotion/affect_behav | 0.51121790 |
| 94 | MP0001944_abnormal_pancreas_morphology | 0.50660258 |
| 95 | MP0002229_neurodegeneration | 0.49950573 |
| 96 | MP0002733_abnormal_thermal_nociception | 0.49773860 |
| 97 | MP0002638_abnormal_pupillary_reflex | 0.49017955 |
| 98 | MP0003718_maternal_effect | 0.48074735 |
| 99 | MP0000647_abnormal_sebaceous_gland | 0.47881443 |
| 100 | MP0002168_other_aberrant_phenotype | 0.47631117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal pancreas size (HP:0012094) | 8.05902033 |
| 2 | Increased serum pyruvate (HP:0003542) | 5.73792554 |
| 3 | Shawl scrotum (HP:0000049) | 5.53129283 |
| 4 | Large eyes (HP:0001090) | 5.04453673 |
| 5 | Abnormality of glycolysis (HP:0004366) | 4.99135404 |
| 6 | Decreased circulating renin level (HP:0003351) | 4.97728620 |
| 7 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.25098115 |
| 8 | Abnormality of alanine metabolism (HP:0010916) | 4.25098115 |
| 9 | Hyperalaninemia (HP:0003348) | 4.25098115 |
| 10 | Metabolic alkalosis (HP:0200114) | 4.03229795 |
| 11 | Alveolar cell carcinoma (HP:0006519) | 3.75363784 |
| 12 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 3.51997348 |
| 13 | Ulnar claw (HP:0001178) | 3.49722786 |
| 14 | Cerebellar dysplasia (HP:0007033) | 3.30175636 |
| 15 | Neoplasm of the tracheobronchial system (HP:0100552) | 3.20107218 |
| 16 | Irregular vertebral endplates (HP:0003301) | 3.05200449 |
| 17 | Optic nerve hypoplasia (HP:0000609) | 3.01795437 |
| 18 | Type II lissencephaly (HP:0007260) | 2.96635011 |
| 19 | Rhabdomyosarcoma (HP:0002859) | 2.90013001 |
| 20 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.83142552 |
| 21 | Pancreatic cysts (HP:0001737) | 2.80173710 |
| 22 | Absent epiphyses (HP:0010577) | 2.79161179 |
| 23 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.79161179 |
| 24 | Abnormality of renin-angiotensin system (HP:0000847) | 2.77395363 |
| 25 | Genu recurvatum (HP:0002816) | 2.76627206 |
| 26 | Abnormality of the renal cortex (HP:0011035) | 2.75081150 |
| 27 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.67093606 |
| 28 | Disproportionate short-trunk short stature (HP:0003521) | 2.65159893 |
| 29 | Midline defect of the nose (HP:0004122) | 2.53318272 |
| 30 | Occipital encephalocele (HP:0002085) | 2.50180107 |
| 31 | Hypophosphatemic rickets (HP:0004912) | 2.50085714 |
| 32 | Supranuclear gaze palsy (HP:0000605) | 2.49858996 |
| 33 | Slow-growing hair (HP:0002217) | 2.48555122 |
| 34 | Abnormality of hair growth rate (HP:0011363) | 2.48555122 |
| 35 | Decreased subcutaneous fat (HP:0001002) | 2.46955125 |
| 36 | Cerebral palsy (HP:0100021) | 2.46348745 |
| 37 | Meningocele (HP:0002435) | 2.41538686 |
| 38 | Thoracolumbar scoliosis (HP:0002944) | 2.39909980 |
| 39 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.35802719 |
| 40 | Partial agenesis of the corpus callosum (HP:0001338) | 2.35620376 |
| 41 | Abnormality of the vertebral endplates (HP:0005106) | 2.34755697 |
| 42 | Neoplasm of striated muscle (HP:0009728) | 2.34126993 |
| 43 | Absent thumb (HP:0009777) | 2.33827785 |
| 44 | Abnormal drinking behavior (HP:0030082) | 2.29819540 |
| 45 | Polydipsia (HP:0001959) | 2.29819540 |
| 46 | Stomatitis (HP:0010280) | 2.29475445 |
| 47 | Renal cortical cysts (HP:0000803) | 2.27436154 |
| 48 | Hypokalemia (HP:0002900) | 2.26349155 |
| 49 | Retinal dysplasia (HP:0007973) | 2.26110652 |
| 50 | Abnormality of midbrain morphology (HP:0002418) | 2.25059470 |
| 51 | Molar tooth sign on MRI (HP:0002419) | 2.25059470 |
| 52 | Cortical visual impairment (HP:0100704) | 2.24931394 |
| 53 | Breast carcinoma (HP:0003002) | 2.18978099 |
| 54 | Inability to walk (HP:0002540) | 2.18161571 |
| 55 | White forelock (HP:0002211) | 2.17398561 |
| 56 | Patellar aplasia (HP:0006443) | 2.16435925 |
| 57 | Maternal diabetes (HP:0009800) | 2.13839449 |
| 58 | Irregular epiphyses (HP:0010582) | 2.11592219 |
| 59 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.08587233 |
| 60 | Patchy hypopigmentation of hair (HP:0011365) | 2.05710001 |
| 61 | Severe muscular hypotonia (HP:0006829) | 2.04668485 |
| 62 | Abnormality of the intervertebral disk (HP:0005108) | 2.04242889 |
| 63 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.02674266 |
| 64 | Pancreatic fibrosis (HP:0100732) | 2.02019118 |
| 65 | True hermaphroditism (HP:0010459) | 2.01980833 |
| 66 | Amaurosis fugax (HP:0100576) | 2.01281652 |
| 67 | Polyuria (HP:0000103) | 1.97090448 |
| 68 | Cystic liver disease (HP:0006706) | 1.95942444 |
| 69 | Progressive inability to walk (HP:0002505) | 1.95713858 |
| 70 | Abnormality of the right ventricle (HP:0001707) | 1.95548168 |
| 71 | Alkalosis (HP:0001948) | 1.94535957 |
| 72 | Epidermoid cyst (HP:0200040) | 1.94509929 |
| 73 | Subcapsular cataract (HP:0000523) | 1.94217409 |
| 74 | Abnormality of the renal medulla (HP:0100957) | 1.89348947 |
| 75 | Oligohydramnios (HP:0001562) | 1.89163199 |
| 76 | Thick nail (HP:0001805) | 1.88343386 |
| 77 | Thyroid-stimulating hormone excess (HP:0002925) | 1.87586544 |
| 78 | Congenital sensorineural hearing impairment (HP:0008527) | 1.84893939 |
| 79 | Bulbous nose (HP:0000414) | 1.81996602 |
| 80 | Patent foramen ovale (HP:0001655) | 1.80668696 |
| 81 | Short chin (HP:0000331) | 1.80070311 |
| 82 | Abnormality of potassium homeostasis (HP:0011042) | 1.79859085 |
| 83 | Nephronophthisis (HP:0000090) | 1.78981737 |
| 84 | Asplenia (HP:0001746) | 1.78664293 |
| 85 | Lip pit (HP:0100267) | 1.78013108 |
| 86 | Mesangial abnormality (HP:0001966) | 1.76419676 |
| 87 | Dandy-Walker malformation (HP:0001305) | 1.73352978 |
| 88 | Tinnitus (HP:0000360) | 1.72591319 |
| 89 | Broad nasal tip (HP:0000455) | 1.72560000 |
| 90 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.71096368 |
| 91 | Lissencephaly (HP:0001339) | 1.70748355 |
| 92 | Congenital hepatic fibrosis (HP:0002612) | 1.70706764 |
| 93 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.70116263 |
| 94 | Type I diabetes mellitus (HP:0100651) | 1.68712326 |
| 95 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.66926600 |
| 96 | Congenital stationary night blindness (HP:0007642) | 1.66651771 |
| 97 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.66539071 |
| 98 | Sprengel anomaly (HP:0000912) | 1.65918607 |
| 99 | Biliary tract neoplasm (HP:0100574) | 1.61733541 |
| 100 | Constricted visual fields (HP:0001133) | 1.61259344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 4.83975193 |
| 2 | ADRBK2 | 4.10379238 |
| 3 | TAOK3 | 3.50922137 |
| 4 | BCKDK | 3.30696047 |
| 5 | FRK | 3.23119526 |
| 6 | TRIM28 | 2.90824656 |
| 7 | MAP2K2 | 2.47964210 |
| 8 | RPS6KA4 | 2.42536010 |
| 9 | IKBKB | 2.19663622 |
| 10 | TAOK1 | 2.14480731 |
| 11 | NEK6 | 2.06636547 |
| 12 | ZAK | 1.99038626 |
| 13 | BMPR1B | 1.93235516 |
| 14 | GRK1 | 1.92672141 |
| 15 | NTRK2 | 1.91552041 |
| 16 | TXK | 1.86481847 |
| 17 | BRD4 | 1.84322137 |
| 18 | CHUK | 1.82245822 |
| 19 | PRKD3 | 1.78883290 |
| 20 | IRAK4 | 1.69130339 |
| 21 | MAP2K7 | 1.67223398 |
| 22 | WNK4 | 1.55084004 |
| 23 | ADRBK1 | 1.54917525 |
| 24 | WNK3 | 1.54208736 |
| 25 | STK38L | 1.48204814 |
| 26 | MAPK13 | 1.48055291 |
| 27 | TNK2 | 1.43104572 |
| 28 | MAP3K4 | 1.33534252 |
| 29 | PRKCI | 1.28827076 |
| 30 | FLT3 | 1.28515153 |
| 31 | MAP3K2 | 1.27053331 |
| 32 | EPHA4 | 1.25566712 |
| 33 | CASK | 1.23122400 |
| 34 | PRKCQ | 1.18702978 |
| 35 | LATS1 | 1.15424785 |
| 36 | MARK3 | 1.12504035 |
| 37 | FGFR2 | 1.10317316 |
| 38 | IKBKE | 1.09216812 |
| 39 | WNK1 | 1.04282521 |
| 40 | INSRR | 1.01389954 |
| 41 | MAP4K1 | 0.97213564 |
| 42 | KIT | 0.91355423 |
| 43 | PLK4 | 0.90909731 |
| 44 | GRK5 | 0.87288840 |
| 45 | MAP3K6 | 0.85584704 |
| 46 | EPHB2 | 0.85553641 |
| 47 | GRK6 | 0.79383195 |
| 48 | GRK7 | 0.75246286 |
| 49 | TGFBR1 | 0.73403480 |
| 50 | PNCK | 0.72919845 |
| 51 | MAP2K1 | 0.72855397 |
| 52 | RPS6KA5 | 0.72045640 |
| 53 | PKN2 | 0.69352606 |
| 54 | LIMK1 | 0.66254410 |
| 55 | STK24 | 0.66110147 |
| 56 | PKN1 | 0.65821370 |
| 57 | TLK1 | 0.65220369 |
| 58 | DAPK2 | 0.64029557 |
| 59 | NEK2 | 0.62951416 |
| 60 | PIK3CG | 0.62859263 |
| 61 | MAP4K2 | 0.62090395 |
| 62 | CDK7 | 0.62045666 |
| 63 | DYRK1B | 0.57024049 |
| 64 | DYRK2 | 0.54761611 |
| 65 | ITK | 0.52832848 |
| 66 | MAP2K4 | 0.50344503 |
| 67 | PRKCG | 0.49127851 |
| 68 | KDR | 0.47653785 |
| 69 | PRKD1 | 0.46844727 |
| 70 | TBK1 | 0.46458495 |
| 71 | MKNK2 | 0.46402972 |
| 72 | ACVR1B | 0.46203434 |
| 73 | ERBB2 | 0.43518065 |
| 74 | BTK | 0.42299492 |
| 75 | FER | 0.41537727 |
| 76 | OXSR1 | 0.39651107 |
| 77 | PRKD2 | 0.38843250 |
| 78 | LYN | 0.38518404 |
| 79 | GSK3A | 0.38160491 |
| 80 | TEC | 0.35451709 |
| 81 | RPS6KA1 | 0.35225810 |
| 82 | STK38 | 0.34460466 |
| 83 | DYRK1A | 0.34044780 |
| 84 | CAMK2D | 0.33777364 |
| 85 | SYK | 0.32722249 |
| 86 | CDK19 | 0.32452952 |
| 87 | EPHA3 | 0.32443082 |
| 88 | STK11 | 0.31713558 |
| 89 | PRKCZ | 0.28408375 |
| 90 | MATK | 0.28305235 |
| 91 | PIM1 | 0.28150710 |
| 92 | PRKAA2 | 0.27639902 |
| 93 | CAMK1 | 0.26858520 |
| 94 | PRKCH | 0.26080176 |
| 95 | PRKACA | 0.25376584 |
| 96 | PRKCA | 0.21558659 |
| 97 | STK39 | 0.20777808 |
| 98 | CDK8 | 0.19786095 |
| 99 | RPS6KA2 | 0.19046262 |
| 100 | CSNK1A1 | 0.18642963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.09885335 |
| 2 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.07179225 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.74586977 |
| 4 | Basal transcription factors_Homo sapiens_hsa03022 | 2.68223211 |
| 5 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.58723810 |
| 6 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.44843346 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.43358237 |
| 8 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.35958467 |
| 9 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.26655004 |
| 10 | Peroxisome_Homo sapiens_hsa04146 | 2.19823148 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.17332455 |
| 12 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.99709793 |
| 13 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.96113532 |
| 14 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.91222398 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 1.90870525 |
| 16 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.84027568 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.71497699 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.68454866 |
| 19 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.66025148 |
| 20 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.61964888 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.57743877 |
| 22 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.57479897 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.49516366 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.48976672 |
| 25 | Axon guidance_Homo sapiens_hsa04360 | 1.47439410 |
| 26 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.44552008 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.44007268 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.41038480 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.34168277 |
| 30 | Nicotine addiction_Homo sapiens_hsa05033 | 1.30791228 |
| 31 | Olfactory transduction_Homo sapiens_hsa04740 | 1.29628207 |
| 32 | Mineral absorption_Homo sapiens_hsa04978 | 1.28854920 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.26013399 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.22570872 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.16623744 |
| 36 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.15623903 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.13451729 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.05327195 |
| 39 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.05252002 |
| 40 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.00320700 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.00104213 |
| 42 | Salivary secretion_Homo sapiens_hsa04970 | 0.99441031 |
| 43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.99369451 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.97961547 |
| 45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.97345851 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.96557902 |
| 47 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.94548549 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.91609966 |
| 49 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.88652716 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 0.87520967 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87150963 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83952111 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83593829 |
| 54 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82246215 |
| 55 | Circadian entrainment_Homo sapiens_hsa04713 | 0.78795830 |
| 56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.77243377 |
| 57 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.76060866 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75237446 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74540719 |
| 60 | Parkinsons disease_Homo sapiens_hsa05012 | 0.72937212 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67294172 |
| 62 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.67205280 |
| 63 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66825941 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64695960 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63228163 |
| 66 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.63149322 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.62566502 |
| 68 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.61855021 |
| 69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60954724 |
| 70 | RNA degradation_Homo sapiens_hsa03018 | 0.60507565 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59992636 |
| 72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58952264 |
| 73 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54150364 |
| 74 | Renin secretion_Homo sapiens_hsa04924 | 0.53761530 |
| 75 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52878735 |
| 76 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.52305830 |
| 77 | Homologous recombination_Homo sapiens_hsa03440 | 0.50793719 |
| 78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.49305832 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48579031 |
| 80 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.48438488 |
| 81 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.48058051 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48029940 |
| 83 | Huntingtons disease_Homo sapiens_hsa05016 | 0.47920349 |
| 84 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47556308 |
| 85 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.45865562 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43560526 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42455900 |
| 88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.41664780 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40727682 |
| 90 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.38968611 |
| 91 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.38153932 |
| 92 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.38043972 |
| 93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.35290734 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34109028 |
| 95 | Sulfur relay system_Homo sapiens_hsa04122 | 0.33692803 |
| 96 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.33160807 |
| 97 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.33108261 |
| 98 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.32769556 |
| 99 | Other glycan degradation_Homo sapiens_hsa00511 | 0.32223993 |
| 100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.31359771 |

